Glenmark Pharmaceuticals Ltd.
Snapshot View

View in App

Prices View details >>

392.40 -6.80 ▼-1.7%

07 February 2023, 04:01:00 PM
Volume: 20,648

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.glenmarkpharma.com
Market Cap 11,072.28 Cr.
Enterprise Value(EV) 13,786.30 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 29.43 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 13.33 Trailing Twelve Months Ending 2022-09
Industry PE 32.80 Trailing Twelve Months Ending 2022-09
Book Value / Share 339.27 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.16 Calculated using Price: 392.40
Dividend Yield 0.64 Period Ending 2022-03
No. of Shares Subscribed 28.22 Cr. 282,168,156 Shares
FaceValue 1
Company Profile
The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Specialty Business: Drug Discovery: Glenmark's ground-breaking drug discovery effort is primarily focused in the areas of inflammation [asthma/COPD, rheumatoid arthritis etc.], metabolic disorders [diabetes, obesity, etc.] and pain [neuropathic pain and inflammatory pain]. Specialty Business: Formulations Business: Glenmark's formulations business is currently organized many regions - India, Latin America, Central Eastern Europe and Semi Regulated Markets of Africa/Asia/CIS. The formulations business focuses on therapeutic areas viz. dermatology, anti-infective, respiratory, cardiac, diabetes, gynecology, CNS, and oncology.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.70%
1 Week
+2.12%
1 Month
-7.15%
3 Month
-7.22%
6 Month
+3.74%
1 Year
-19.89%
2 Year
-22.06%
5 Year
-31.12%
10 Year
-20.97%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 18.99 8.79 27.46 27.31 16.67 17.21 13.32 14.81 12.33
Return on Capital Employed (%) 15.04 12.40 18.53 20.54 14.77 16.47 14.04 15.30 14.19
Return on Assets (%) 7.51 2.58 8.52 11.33 7.40 7.98 6.17 7.11 6.74

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 2,983 1,783 3,630 4,493 5,163 5,605 6,071 7,065 9,087 9,573
Non Curr. Liab. 1,967 2,749 1,499 3,258 2,824 2,280 3,033 2,804 1,270 2,342
Curr. Liab. 2,949 3,777 3,999 2,703 3,288 4,021 4,126 4,201 4,689 4,198
Minority Int. 13 0 0 0 0 0 0 0 351 366
Equity & Liab. 7,912 8,309 9,128 10,453 11,275 11,906 13,229 14,069 15,397 16,479
Non Curr. Assets 3,150 2,978 3,224 3,578 4,286 5,209 6,425 6,709 7,115 7,520
Curr. Assets 4,763 5,331 5,904 6,875 6,989 6,697 6,804 7,360 8,282 8,959
Misc. Exp. not W/O
Total Assets 7,912 8,309 9,128 10,453 11,275 11,906 13,229 14,069 15,397 16,479

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 5,945 6,681 7,562 9,079 9,074 9,865 10,641 10,944 12,305 12,345
Other Income 11 7 20 37 91 208 160 50 167 402
Total Income 5,956 6,688 7,582 9,117 9,166 10,074 10,801 10,994 12,472 12,747
Total Expenditure -4,854 -5,467 -6,125 -7,043 -7,459 -8,280 -8,943 -8,860 -9,985 -10,135
PBIDT 1,102 1,221 1,457 2,074 1,707 1,794 1,858 2,135 2,487 2,611
Interest -189 -190 -179 -237 -286 -335 -377 -353 -298 -297
Depreciation -217 -300 -234 -264 -302 -326 -417 -444 -487 -553
Taxation -151 -334 -301 -383 -315 -376 -320 -412 -448 -599
Exceptional Items -187 -81 167 33 45 -261 -261
PAT 546 209 743 1,109 804 925 776 970 994 902
Minority Interest -3 0 0 0 0 0 0 -52 -72
Share Associate
Other Related Items
Consolidated Net Profit 542 210 743 1,109 804 925 776 970 942 830
Adjusted EPS 20 8 26 39 28 33 28 34 33 29

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 648 854 482 345 657 1,648 1,324 1,392 1,131 1,109
Cash Fr. Inv. -464 -368 -540 -880 -712 -1,013 -699 -784 -675 -333
Cash Fr. Finan. 195 -98 199 699 543 -469 -739 -445 -442 -520
Net Change 379 388 141 163 488 166 -114 164 14 255
Cash & Cash Eqvt 605 795 764 857 1,056 1,233 936 1,110 1,138 1,411

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 46.63 46.63 46.63 46.65 46.65 46.65 46.65 46.65 46.65
Public 53.37 53.37 53.37 53.35 53.35 53.35 53.35 53.35 53.35
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 27 Jan 2023
Update On The Company''s Baddi (India) Facility
Update on the Companys Baddi (India) Facility
Mon, 23 Jan 2023
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark launches AKYNZEO® I.V. in India - First Fixed I.V. Antiemetic Combination for the Prevention of Chemotherapy-induced Nausea and Vomiting
Tue, 17 Jan 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Enclosed please find herewith the details of Earnings Call slated for Monday February 13 2023 at 9:30 a.m. - 10:30 a.m. (IST) for your information and record. Please note that the recording of the call will be available on our website within 24 hours of the call.

Technical Scans View Details >>

Tue, 07 Feb 2023
Opening at High Opening at High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
William %R Trending Down William %R Trending Down
Darkcloud Cover Darkcloud Cover

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 241,289.12 1,005.65 -1.7%
Cipla Ltd. 83,256.90 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. 73,968.14 4,441.90 +2.1%
Divi's Laboratories Ltd. 72,982.62 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. 62,135.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. 51,898.92 1,533.45 -0.4%
Zydus Lifesciences Ltd. 48,525.07 479.40 +2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.29 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 31.56 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.30 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 30.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 74.00 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.45 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.54 479.40 +2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.36 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-12 3.67 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.36 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-12 5.87 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.38 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.14 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.81 479.40 +2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 0.04 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 479.40 +2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 13.10 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 479.40 +2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 479.40 +2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,005.65 -1.7%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,031.50 +0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,441.90 +2.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,749.20 -1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,321.40 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,533.45 -0.4%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 479.40 +2.0%

FAQ's On Glenmark Pharmaceuticals Ltd.

What is Glenmark Pharma share price?
Can I buy Glenmark Pharma shares now?
What is the Dividend Yield of Glenmark Pharma?
What is the Market Cap of Glenmark Pharma?
What are the key metrics to analyse Glenmark Pharma?
What is the 52 Week High and Low of Glenmark Pharma?
What is the trend of Glenmark Pharma share price?